Cargando…
Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain
Endomorphins are endogenous opioid peptides that cause potent antinociception in rodent models of acute and neuropathic pain with less undesirable side effects than opioid alkaloids. However, endomorphins are poorly suited to clinical applications because of low membrane permeability and a susceptib...
Autores principales: | Varamini, Pegah, Toth, Istvan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862115/ https://www.ncbi.nlm.nih.gov/pubmed/24379782 http://dx.doi.org/10.3389/fphar.2013.00155 |
Ejemplares similares
-
Lipo-Endomorphin-1 Derivatives with Systemic Activity against Neuropathic Pain without Producing Constipation
por: Varamini, Pegah, et al.
Publicado: (2012) -
Experimental Gene Therapy with Serine-Histogranin and Endomorphin 1 for the Treatment of Chronic Neuropathic Pain
por: Jergova, Stanislava, et al.
Publicado: (2017) -
Simultaneous intrathecal injection of muscimol and endomorphin‐1 alleviates neuropathic pain in rat model of spinal cord injury
por: Hosseini, Marjan, et al.
Publicado: (2020) -
Immunotherapy targeting cytokines in neuropathic pain
por: Lees, Justin G., et al.
Publicado: (2013) -
Viral vectors encoding endomorphins and serine histogranin attenuate neuropathic pain symptoms after spinal cord injury in rats
por: Nasirinezhad, Farinaz, et al.
Publicado: (2015)